Company intelligence / Profile preview

Ceros Pharmaceuticals

Cambridge, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Ceros Pharmaceuticals was a private biopharmaceutical company focused on developing compounds for osteoporosis and related bone diseases. Publicly available information indicates the company was based in Cambridge, United Kingdom, though some secondary sources also associate it with Houston, Texas. The company appears to have had a small early-stage pipeline centered on bone biology, with at least one disclosed asset, AUX-102, later folded into Auxeris Therapeutics. Ceros Pharmaceuticals was acquired by Auxeris Therapeutics, and it does not appear to operate today as an independent active company.

Therapeutic areas: EndocrinologyRheumatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Ceros Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceros Pharmaceuticals.

Explore the full profile